Scaling Up Screening in 96- & 384-Well Microplates

VIAFLO Assist with VIAFLO II electronic pipette

INTEGRA reports on how researchers at the Health Innovation Research Institute at RMIT University (Bundoora, Australia) are using VIAFLO II electronic pipettes in conjunction with a VIAFLO ASSIST to scale-up their screening of venoms and small compounds.

The Health Innovations Research Institute (HIRi) is an RMIT University initiative that seeks to address key health issues facing Australia in the 21st century, with research programs that examine how the human body functions at a molecular and cellular level.

This research is targeted to provide innovative therapeutic strategies to improve the health and wellbeing of people in Australia and around the world.

We approached INTEGRA’s Australian distributor (BioTools Pty Ltd.) for a solution to scale-up our screening of venoms and small compounds in both 96- and 384-well plates. Following a demonstration we found that the VIAFLO ASSIST pipetting assistant met our required criteria of a cost effective and easy to use pipetting solution, which lead us to purchase the ASSIST and 3 VIAFLO II multichannel pipettes”.

Mr Darby added “Since its introduction, the system has been running perfectly and we have been able to achieve the scaling-up we required. The ASSIST has delivered more accurate and precise pipetting results that have improved our assay results. Another significant benefit is that the ASSIST is very compact and easily fits in our lab hood. We have also found that the versatility of the VIAFLO II pipettes has proven especially useful for handling complicated layouts in 384-well plates.”

Bill Darby, Researcher at HIRi.



Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    INTEGRA Biosciences. (2019, June 24). Scaling Up Screening in 96- & 384-Well Microplates. News-Medical. Retrieved on June 22, 2024 from

  • MLA

    INTEGRA Biosciences. "Scaling Up Screening in 96- & 384-Well Microplates". News-Medical. 22 June 2024. <>.

  • Chicago

    INTEGRA Biosciences. "Scaling Up Screening in 96- & 384-Well Microplates". News-Medical. (accessed June 22, 2024).

  • Harvard

    INTEGRA Biosciences. 2019. Scaling Up Screening in 96- & 384-Well Microplates. News-Medical, viewed 22 June 2024,


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Everything you need to know about next generation sequencing in INTEGRA Biosciences’ eBook